Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM5B | Q9UGL1 | 12/20 | 0.46 |
| ▸ | KDM5C | P41229 | 8/20 | 0.45 |
| ▸ | KDM5A | P29375 | 7/20 | 0.45 |
| ▸ | KDM4A | O75164 | 3/20 | 0.45 |
| ▸ | KDM6B | O15054 | 1/20 | 0.45 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.45 |
| ▸ | KDM4B | O94953 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 4/20 | 0.36 |
| ▸ | KDM5D | Q9BY66 | 1/20 | 0.36 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16291579 | 0.81 | KDM5B (0.62) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL16912746 | 0.81 | KDM5B (0.48) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL15638915 | 0.78 | KDM5B (0.56) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL16292445 | 0.77 | KDM5B (0.49) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL18708529 | 0.76 | KDM5B (0.55) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL16912750 | 0.76 | KDM5B (0.46) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL16291681 | 0.71 | KDM5B (0.54) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL17772477 | 0.71 | KDM5B (0.35) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL16291806 | 0.71 | KDM5B (0.53) | KDM5BKDM5CKDM5AKDM4AKDM6B | |
| SCHEMBL16291432 | 0.70 | KDM5B (0.39) | KDM5BKDM5CKDM5AKDM4AKDM6B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10189787-B2 | Inhibitors of histone demethylases | GILEAD SCIENCES, INC. (US) | 2019-01-29 | — | — | US | disclosed |
| US-9611220-B2 | — | — | 2017-04-04 | — | — | US | disclosed |
| US-20140371195-A1 | INHIBITORS OF HISTONE DEMETHYLASES | GILEAD SCIENCES, INC. | 2014-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10189787-B2 | Inhibitors of histone demethylases | EHMT1, KDM1B, EHMT2 | KDM5B 34/4885KDM5C 31/4885KDM5A 24/4885 |
| US-20140371195-A1 | INHIBITORS OF HISTONE DEMETHYLASES | EHMT1, KDM1B, EHMT2 | KDM5B 34/4885KDM5C 31/4885KDM5A 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.